Dr Reddys to spend upto $300 million on R&D in FY 20
The R&D spend for the quarter (January-March FY 19) is Rs 366 crore, that is USD 53 million and EBIT 9.19 per cent of the sales for the quarter, said Saumen Chakraborty, President, CFO and global head (HR) of Dr Reddy.
Replying to a query, Israeli said the company during FY 20 expects to launch more than 30 products in the US market. Reuters